Product news

An FDA advisory panel voted that a long-acting, injectable form of Eli Lilly's best-selling drug, the antipsychotic olanzapine, is safe enough for use in some patients with schizophrenia. But panel members shared concerns raised by the FDA that Zyprexa LAI was associated with excessive sedation.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel